| Names | |
|---|---|
| Preferred IUPAC name | 1,3,7-Trimethylpurine-2,6-dione |
| Other names | 1,3,7-Trimethylxanthine Guaranine Methyltheobromine Theine |
| Pronunciation | /ˈkæf.i.iːn/ |
| Identifiers | |
| CAS Number | 58-08-2 |
| 3D model (JSmol) | `3Dmodel:JSmol|string:CN1C=NC2=C1C(=O)N(C(=O)N2C)C` |
| Beilstein Reference | 358078 |
| ChEBI | CHEBI:27732 |
| ChEMBL | CHEMBL113 |
| ChemSpider | 2424 |
| DrugBank | DB00201 |
| ECHA InfoCard | 03bb513a-16f0-4c7a-9880-5c8e4d6b8158 |
| EC Number | 3.1.4.16 |
| Gmelin Reference | Gmelin Reference: 83150 |
| KEGG | C07481 |
| MeSH | D002110 |
| PubChem CID | 2519 |
| RTECS number | CAS6440 |
| UNII | 3G6A5W338E |
| UN number | 1544 |
| Properties | |
| Chemical formula | C8H10N4O2 |
| Molar mass | 194.19 g/mol |
| Appearance | White, odorless, crystalline powder |
| Odor | Odorless |
| Density | 1.2 g/cm³ |
| Solubility in water | Moderately soluble (2 g/100 mL at 25 °C) |
| log P | -0.07 |
| Vapor pressure | 0.00036 mmHg at 25°C |
| Acidity (pKa) | pKa = 14.0 |
| Basicity (pKb) | 10.4 |
| Magnetic susceptibility (χ) | -18.1 × 10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.582 |
| Dipole moment | 2.59 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 192.0 J/mol·K |
| Std enthalpy of formation (ΔfH⦵298) | -230.7 kJ·mol⁻¹ |
| Std enthalpy of combustion (ΔcH⦵298) | −5074 kJ/mol |
| Pharmacology | |
| ATC code | N06BC01 |
| Hazards | |
| Main hazards | Harmful if swallowed. Causes serious eye irritation. May cause respiratory irritation. |
| GHS labelling | GHS02, GHS07 |
| Pictograms | GHZWD |
| Signal word | Warning |
| Hazard statements | H302, H315, H319, H335 |
| Precautionary statements | P264, P270, P301+P312, P330, P501 |
| Flash point | 178°C |
| Autoignition temperature | 410 °C |
| Explosive limits | Explosive limits: "0.7–3.9% |
| Lethal dose or concentration | LD₅₀ (oral, rat): 192 mg/kg |
| LD50 (median dose) | LD50: 192 mg/kg (oral, rat) |
| NIOSH | UN1544 |
| PEL (Permissible) | PEL (Permissible Exposure Limit) of Caffeine is "10 mg/m³". |
| REL (Recommended) | 400 mg/day |
| IDLH (Immediate danger) | Unknown |
| Related compounds | |
| Related compounds | Theophylline Theobromine Paraxanthine Methylliberine |
| Property | Description | Manufacturer Commentary |
|---|---|---|
| Product Name | Caffeine | Caffeine is produced to multiple specification levels depending on pharmaceutical, food, or industrial end-use. Sourcing decisions consider impurity profiles associated with each market segment. |
| IUPAC Name | 1,3,7-Trimethylpurine-2,6-dione | This systematic name reflects the standard purine core structure with three methyl substitutions. The naming underlines the priority of isomeric control in route optimization, especially for high-purity applications. |
| Chemical Formula | C8H10N4O2 | The empirical formula aligns across all industrially relevant grades. Isotope distribution or trace adducts are flagged mainly in pharmaceutical release testing but less so in technical grades. |
| CAS Number | 58-08-2 | Manufacturing labels and batch records reference the CAS number to support international regulatory traceability. Identification practices are grade-specific with more extensive documentation for GMP-grade caffeine. |
| Synonyms & Trade Names | Methyltheobromine, 1,3,7-Trimethylxanthine, Guaranine, Mateine | On technical documentation and shipping records, synonyms are listed to accommodate regional terminology and mitigate cross-border confusion. Nomenclature harmonization is regularly updated in response to regulatory changes. |
| HS Code & Customs Classification | 2939.30 | HS Code selection follows World Customs Organization descriptions and is verified against the latest import/export regulations for each destination. Shipment documentation includes specific HS codes reflecting the form (bulk powder, granules, or compounded blend) to avoid clearance delays. |
Caffeine production draws raw materials primarily from natural extraction (coffee/tea plant sources) or by synthetic route from dimethylurea and malonic acid derivatives. Route selection pivots on raw material cost fluctuation, solvent consumption, and downstream purification expense. Natural extraction targets beverage and food segment requirements, especially for markets specifying “natural source” origin. In contrast, synthetic routes support technical and laboratory grade supply, where uniformity and availability outweigh sourcing disclosure.
Process controls focus on methylxanthine isomer co-extraction, residual solvent removal, and consistent particle size. Manufacturers apply chromatography, solvent crystallization, or filtration as core purification methods, depending on targeted grade and regional market expectation. Impurity management includes continuous monitoring of theobromine, heavy metals from plant or process origin, and solvent carryover. Final release standards are defined per application—pharma grades reference pharmacopeia monographs, food grades align with global additive requirements, and technical grades are more flexible with quality indicators.
Batch consistency relies on in-process sampling and tight control of synthesis or extraction parameters. Packaging and labeling include grade, production lot, country of origin (for plant extracts), and applicable regulatory conformity marks. Tailoring release specifications around customer’s downstream requirements addresses both regulatory documentation needs and practical usability in formulation, processing, or re-packaging environments.
In our commercial manufacturing, caffeine typically enters the process as a white to off-white crystalline powder. Bulk lots present a faint bitter odor. The melting point generally falls into a narrow range in pure grades, signaling absence of major contaminants—any broadening or depression of melt range signals process irregularities or cross-contamination. Particle size and bulk density are customized case-by-case: pharmaceutical and beverage customers audit for fine particulate fractions, while technical grades tolerate broader ranges. Granulation impacts flow properties, dissolution rates, and stability in end formulas.
Caffeine shows strong resilience toward air and ambient temperature in its dry form—hydrolysis and thermal degradation emerge as primary risks in storage and processing. Exposure to acidic or basic conditions, particularly in aqueous solutions, can prompt slow decomposition, generating impurities such as dimethylurea and methylxanthines. Light exposure in solution accelerates color development and profile deterioration.
Solubility depends heavily on temperature and grade: higher-purity caffeine demonstrates increased solubility in hot water and polar solvents. Beverage and injectable grades require careful pH and buffer selection during dissolution to avoid haze or precipitation (stemming from minor alkaloidal impurities). Technical process guidelines recommend solution preparation close to use to limit microbial and hydrolytic breakdown.
Manufacturing offers multiple grades: food, pharmaceutical, and technical. Each grade defines minimum purity and acceptable impurity levels, tailored by industry. Analytical grades face stricter controls for residual solvents, heavy metals, and secondary xanthines.
| Parameter | Pharma Grade | Food Grade | Technical Grade |
|---|---|---|---|
| Assay | Defined per pharmacopeia | Industry-specific limit | Grade-specific range |
| Impurities | Tighter limits | Moderate limits | Lowest requirement |
| Moisture | Critical for injection use | Food additive standards | Process-driven tolerance |
Profile varies with source and process. Key impurities: theobromine, theophylline, dimethylurea, and trace organics from raw materials or solvents. Release specifications are batch-wise and dictated by both regulation and customer audit requirements. Continual internal monitoring along with external laboratory verification keeps adulterant risk controlled.
Most customers request compliance with pharmacopeial references (USP, EP) for assay and impurities. Chromatographic fingerprinting ensures identity and purity; elemental analysis confirms low background contamination. Analytical method selection is tied to the intended application and buyer expectation.
Caffeine starts from two primary origins: natural extraction or chemical synthesis. Coffee and tea waste streams dominate natural sourcing; synthetic origin depends on urea, methylating agents, and xanthine reactants. Material screening considers both contaminant profiles and geographical supply fluctuations to avoid regulatory noncompliance or supply bottlenecks.
Synthetic caffeine production often leverages methylation of theobromine or direct cyclization from dimethylurea and cyanoacetic acid. Route selection weighs cost, byproduct management, and waste treatment requirements. Extraction plants optimize solvent-use strategy and purification to reduce co-extractant carryover.
Critical controls: solvent purity, reaction temperature, separation parameters, and drying protocols. Natural extract routes demand high-performance filtration and multiple crystallization cycles; synthetic lines deploy advanced distillation and solvent recovery. Process modifications focus on impurity rejection and bulk yield optimization.
Quality control monitors compliance at each key step: in-process samples pass through assay, residual solvent checks, and profile fingerprinting. Only batches matched to pre-defined limits and applications (e.g., injection-grade, food additive) proceed to release. Final approval relies on both automated data and human oversight.
Caffeine undergoes N-demethylation, oxidation, and alkylation under controlled lab or industrial settings. Reactivity increases in the presence of strong acids, bases, or oxidants. Impurity formation during these processes, especially under elevated temperatures, remains a major concern for downstream refiners.
Process safety demands low-temperature operation wherever possible to minimize unwanted byproducts. Solvent selection depends on final process volume and downstream recovery needs. Catalysts, where used, must not introduce extraneous metals, as these impact both product quality and regulatory acceptance.
Caffeine serves as the precursor for many xanthine-related pharmaceuticals and specialty chemicals. N-alkylation, halogenation, and selective oxidation spawn therapeutic and specialty derivatives used in medicine and biochemical research. All modification work adheres to separate impurity and toxicology assessments before scale-up.
Warehouse guidance separates caffeine from moisture sources and high-humidity zones. Direct sunlight prompts photodegradation over extended periods, so container opacity and warehouse lighting receive priority in installation planning. Temperature excursions above room temperature, either in transport or local storage, result in caking or color shifts—typical warning signs batch-wise.
Bulk shipments use fiber drums or HDPE-lined bags with tamper evidence and vapor barriers. Compatibility testing considers product agitation during transit (to avoid fines generation) and interaction potential with packaging adhesives or surfactants. Any unusual odor or color shift during storage points to packaging breach or upstream contamination.
Shelf life is linked to environmental consistency: higher purity and drier storage prolong stability. Degradation manifests as color darkening, odor evolution, or appearance of residual moisture in the packaging. Routine retain-sample inspection forms part of QA for sensitive grades.
Caffeine’s hazard coding aligns with GHS covering acute toxicity, respiratory hazard, and environmental persistence. Official classification and risk phrases depend on jurisdiction and concentration in mixture.
Facility training covers ingestion, inhalation, and contact routes. Dust management and personnel exposure controls address concerns in powder-handling rooms; product-specific material safety information supports risk assessments for downstream customers, especially in food and pharmaceutical applications.
Acute exposure effects include stimulant action, cardiovascular response, and mild respiratory irritation in fine aerosol form; chronic evaluations depend on application, grade, and end-use concentration. Facility exposure guidelines vary: worker rotation, dust extraction, and PPE selection depend on the scale and handling frequency documented in the plant. Toxicological assessment for batch release incorporates both in-process controls and downstream risk communication with industrial partners.
Caffeine manufacturing relies heavily on the selection of botanical raw materials or synthetic intermediates, with capacity shaped by both raw material supply continuity and process route. Plant extraction output depends on crop yields for coffee and tea derivatives, often affected by agricultural cycles, rainfall, and long-term land use changes. Synthetic production, through routes such as uric acid or theophylline methylation, faces supply and allocation limits tied to available reagents and precursor logistics. Overall capacity remains robust in established plants; batch and campaign scheduling handles seasonal spikes in demand, with industrial output commonly contracted in advance to secure downstream integration.
Lead times fluctuate between two weeks and several months, strongly linked to grade and order volume. Pharmaceutical and food-grade volumes, subject to batch-specific analytical release, may require additional validation and extended lead times. Minimum order quantities depend on grade, with higher MOQ for export shipments due to logistics cost, regulatory documentation, and packaging run economics. Custom grades that meet client-specific impurity or trace element thresholds require specialized campaign scheduling and may extend standard lead times.
Standard industrial packaging consists of fiber drums with inner polyethylene liners for bulk shipments. Food and pharmaceutical applications often double-wrap and use inert liners, while smaller packs (1-5 kg) cater to laboratory and specialty sectors. Some customers request packaging validation for direct use in cleanrooms; this often requires documented cleaning of drum exteriors and secondary containment, which can add extra lead time.
Most caffeine exports ship via sea freight in FCL or LCL configurations, with groupage possible for less-than-container volumes. Air shipments generally serve only high-value, urgent, or low-volume requests due to cost. Payment terms favor irrevocable letters of credit for new clients; regular customers may negotiate open account, subject to credit checks and insurance backing. Regulatory documentation, including food or pharmacopeia compliance certificates and country-of-origin declarations, is prepared in line with destination market needs.
Raw material composition varies with production route: botanical extraction grades depend chiefly on green coffee or tea pricing, while synthetic grades track reagent prices—often methylating agents, solvents, and catalyst costs, which fluctuate with global petrochemical inputs or regulatory shifts. Weather events affecting crop outputs directly impact botanical grades, while energy pricing, solvent demand, and regulatory restrictions drive swings in synthetic production costs. Labor, environmental treatment, and certification audit costs are baked into finished product cost, especially for food or pharma registrations.
Grade defines core pricing structure: technical-grade caffeine, with allowances for higher impurity levels and less documentation, sits at a significant discount to food or pharma-grade. Higher-purity demands increase process costs through additional crystallization, purification, and testing steps. Packaging—especially for pharma and infant nutrition grades—incurs certification, traceability, and cleanroom validation costs that can double or triple packaging outlay. Certification against food safety, GMP, or pharmacopoeial standards adds cost through systemic audits, document maintenance, and continuous monitoring.
Raw caffeine prices swing on commodity cycles, especially for extraction routes. Droughts, floods, and disease events in major coffee-producing regions ripple directly into input costs. Synthetic process pricing moves with reagent market volatility and global energy prices. Additional pressure comes from freight, warehousing, and regulatory compliance—such as pesticide residue thresholds or new safety mandates—in export markets. Shifts in environmental compliance requirements (e.g., effluent discharge upgrades) introduce step-changes in underlying cost.
Higher-grade, high-purity, or extra-certified shipments command premiums based on incremental cost of analytic release, batch traceability, and regulatory overhead. Purchasers demanding validated allergen-free packaging or with zero cross-contamination requirements drive additional batch segregation and in-between campaign wash cycles. Regions with strict maximum residue level enforcement and advanced import testing (such as Japan and the EU) often see compliance cost reflected directly in landed price.
Caffeine markets have expanded in line with growth of energy drinks, pharmaceuticals, and functional foods. Tightening regulatory requirements and the steady rise in specialty applications (sports supplements, clinical diagnostics) have shifted consumption toward higher grades. Synthetic production remains centered in East Asia, while plant-extract output remains significant throughout South America and parts of India. Imports and exports continue to respond to container availability, currency movements, and commodity hedging.
United States and European Union maintain high import volumes for pharma and food grades, with significant documentation and regulatory scrutiny. Japan emphasizes purity and residue control, often demanding multiple layers of verification. India and China are both major producers; India focuses on tea-derived extract, while China leads in synthetic caffeine and API manufacturing. Key production clusters continue to invest in emission reduction and process innovations to address both local regulatory needs and export customer requirements.
Expect caffeine prices to remain under upward pressure into 2026 if raw botanical inputs face climate-driven reduction in output. Synthetic grade costs could firm up if upstream petrochemical volatility persists or if export supply chains experience further shocks. Regulatory tightening in major markets, especially over contaminant and residue thresholds, is likely to increase compliance spending and stabilize price at a higher floor. Data based on trade reports, internal production analysis, and regulatory filings from recent years suggests price range tightening between technical and higher-purity grades as compliance costs increasingly affect all supply routes.
This commentary is grounded in internal manufacturing records, major commodity trade publications, reported import/export statistics, customer compliance request patterns, and regulatory filings in key markets. Real-world formulation, campaign production outcomes, and batch release logs inform process and capacity description.
Global supply chains for caffeine faced short-term disruptions during recent port congestion and container shortages, especially impacting long-haul shipments. Sustained demand from beverage and supplement launches in both mature and emerging markets has kept production facilities running at high utilization, with some suppliers expanding capacity or debottlenecking existing lines.
Revisions to maximum residue levels and increased scrutiny of solvent and heavy metal content have prompted both process improvements and expanded documentation at major sites. New non-GMO and allergen-free requirements in the EU and North America have led to additional segregation at facilities and contract lab partnerships. Some regions are introducing stricter limits for pesticide residues in botanical caffeine, which requires upstream supplier audits and batch testing.
Manufacturers have responded with expanded batch retention sampling, investment in in-process controls, and tightened supplier qualification criteria. Campaign planning now includes buffer stock strategies to address logistics delays. Enhanced sampling, validation protocols, and audit documentation processes have been set up in response to evolving customer and regulatory demands. Facility upgrades include segregated storage for food and pharma grades, new batch tracking systems, and additional certified clean areas for export-destined packaging.
Caffeine serves as a critical component across beverages, food, pharmaceuticals, animal health, and personal care industries. The demands from each sector reflect differences in purity, regulatory considerations, and contaminant control. In beverage applications, the most common requirement centers on direct dissolution and taste neutrality. The pharmaceutical sector demands comprehensive impurity profiling and control of trace solvent residues. Animal health applications take a more cautious approach due to species-specific tolerances. In cosmetics, concerns primarily focus on allergenic potential of impurities and compatibility with actives in final formulations. Each of these demands trace back to manufacturing controls, particularly around purity and contamination prevention from raw materials and equipment handling.
| Application Sector | Common Grades Used | Key Parameters |
|---|---|---|
| Carbonated Beverages, Energy Drinks | Food/USP grade | Solubility in cold liquid, taste profile, low odor impact, absence of inorganic and organic impurities at levels aligned with local food regulations |
| Pharmaceutical Formulation | Pharma/USP/EP grade | Impurity limits defined by pharmacopeia, residual solvent profile, batch reproducibility, documentation readiness for regulatory filing |
| Animal Health & Feed | Feed grade, sometimes food grade | Pesticide residue control, absence of allergens, profiling of plant-derived contaminants |
| Personal Care & Cosmetics | Cosmetic/USP or custom-purified | Absence of color-impacting impurities, odor threshold, validation of trace metals and allergenic markers |
Purity drives most application-critical decisions, with impurity profiles differing by application. Taste and organoleptic properties are routinely assessed in beverage formulations, requiring close monitoring of precursors and contaminants that influence flavor. Pharmaceuticals call for validated test methods for residual solvents, specific metals, and organic trace impurities, with lot-to-lot documentation standard practice to facilitate regulatory submission. Custom cosmetic grades may require specific attention to color stability and absence of photoreactive contaminants, which originate during raw material processing or holding times. Feed and animal health use practical residue checks originating from botanical extraction or subsequent purification. Accurate batch control and raw material traceability support downstream reliability and safety, as even low-level cross-contamination can jeopardize consumer trust and product validation.
Industrial users set out by specifying end-use, as the requirements for edible use, therapeutic dosing, or formulation with other actives in cosmetics each call for unique product attributes. Application dictates the grade and guides technical discussion on downstream risks.
Local and export regulatory frameworks define allowable impurity levels, documentation standards, and qualified supplier criteria. Some markets enforce pharmacopoeia compliance, while others apply national food additive standards or cosmetic ingredient safety schemes. Regulatory review at this stage often leads to early technical dialogue with the manufacturing quality control team on in-process documentation and COA format.
Purity targets depend on intended use. Pharmaceutical applications mandate compliance with USP or EP monographs, including validated test results for all listed impurities. Food and beverage customers prioritize flavor profile stability and trace contaminant minimization, relying on finished product analysis and, in certain cases, direct supplier audits of process hygiene controls. Cosmetic manufacturers may require special certifications or batch-specific testing beyond standard food grades. Purity evaluation consists of both numerical purity—as determined by HPLC and GC—and qualitative testing for residual solvents, trace metals, and microbial risk where relevant.
Batch production size aligns with customer consumption volume. Larger-scale users typically work with direct-from-manufacturer shipments, securing technical advantages in batch uniformity and traceability. Custom packing options, bulk consolidation, or regular delivery programs support both budget control and warehouse safety stock management. Lower grades, adequate for feed or some beverage applications, may be used to balance cost against technical acceptance. For research or pilot runs, small-batch, high-purity grades suit technical validation before scale-up orders.
All technical-grade caffeine contracts benefit from in-field validation of actual samples prior to annual supply agreements. Sample testing allows product development teams to characterize solubility profiles, impurity signatures, contamination likelihood, and downstream formulation effects firsthand. Typical practice involves side-by-side comparison against legacy materials or alternative suppliers, feeding back to the manufacturing technical department for final release specification negotiation. Results from customer-specific evaluation inform ongoing technical collaboration, process adjustment, and any extra release controls for specialty applications.
In caffeine manufacturing, every batch reflects the production site’s documented management system. Our operation uses globally recognized standards such as ISO 9001. Such frameworks require ongoing internal audits, corrective action logging, and documented deviation handling. External authorities review not just policies but raw data integrity, sample traceability, and release documentation. Consistency across batches evolves through continuous improvement cycles, focusing on targeted impurity tracking and environmental controls.
Caffeine distributed for pharmaceutical, food, and beverage sectors requires tailored third-party certifications. Grade selection determines applicable dossiers—USP, EP, JP, BP monographs for pharma; FCC for food grade. Regional compliance may also enforce additional safety or purity screenings such as allergen status or contamination risk assessments. As each grade or regulatory destination defines test protocols, detailed certificates of analysis rely on both internal labs and independent verification for certain endpoints.
Customers require traceable documentation for regulatory submissions or internal audits. Document sets commonly include full batch traceability, source material origin, impurity profiles, and in-house or accredited third-party analytical reports. For regulatory-sensitive applications, original signed certificates, method validation data, and shipping condition records accompany standard batch release documentation. Report detail and retention periods depend on product grade, end-use, and supply chain roles.
Direct cooperation with the manufacturing plant provides clear visibility on future capacity. Planning cycles align with bulk orders, spot requirements, or multi-phase development projects. Multi-year purchase frameworks and forecast agreements enable forward allocation, while short-lead order options address smaller or specific project-based needs. Each client may define inventory hold arrangements or specify dual-release shipments to hedge against logistics disruption.
Plant core capacity relies on robust process engineering, validated raw material sources, and failure-mode tracking. Key variables—feedstock purity, solvent recovery rates, stage-wise yield—drive production stability. A multi-line setup or parallel process trains absorb load fluctuations due to scheduled maintenance or demand surges. Batch consistency is maintained with automated controls and statistically supported release protocols. Capability disclosure includes current throughput bands and surge capacity windows set by equipment layout and shift coverage.
Industrial buyers often need pre-shipment sampling for application trials, regulatory filing, or formulation compatibility tests. The sample request process begins with grade identification—FCC, pharma, tech, or feed—followed by documentation of the intended use and required compliance endpoints. Each submission receives internal traceability codes, and corresponding analytical reports reflect the grade’s specification context. Shipping conditions and volume options depend on downstream usage and regional transport constraints.
Supply flexibility considers not only volume scaling but packaging, delivery intervals, stock consignment, and bundled technical support. Some customers implement rolling forecasts with adjustable call-off quantities while others rely on spot or tender-based procurement. Custom packaging, split-batch shipments, or staggered releases meet specialized warehousing or production timelines. Ongoing technical dialogue regarding impurity sensitivity, process changes, or regulatory updates forms part of the long-term cooperation protocol. Technical teams remain available for on-site auditing, troubleshooting, and shared process optimization.
Pharmaceutical synthesis, precision beverage formulation, and nutritional product additive strategies continue to drive caffeine development. Most technical laboratories, including ours, analyze impurity profiles across various synthetic and extraction pathways. Greater attention falls on consistent particle morphology and reduced contamination risks, especially as demand rises for injectable and pediatric formulations where even minor impurities present regulatory hurdles.
Significant growth appears in pharmaceutical excipients, functional foods, cosmeceuticals, and dermal delivery systems. Research groups now pursue controlled-release caffeine complexes, targeting both sports nutrition and medical therapies. In beverage and personal care sectors, user-customizable dosing technologies motivate R&D in microencapsulation, solvent-free processing, and odor-masking carriers. Each segment places different technical demands on purity, solubility, and trace residuals.
Consistent impurity removal—especially for trace xanthines, synthetic byproducts, and solvent residues—remains a production bottleneck. Scale-up of green extraction workflows, such as supercritical CO2 and water-based methods, presents cost and throughput constraints when targeting pharma grades. Analytics must detect contaminants below regional monograph thresholds. Recent breakthroughs in membrane filtration and solid-phase purification improve selectivity and yield but require tailoring to batch size and raw feedstock variability.
Demand from beverage, pharmaceutical, and personal care sectors looks set for incremental growth. Regulatory tightening around residual solvents and non-caffeine xanthine contaminants will split the market further into consumer, food, and pharma-specific grades. Geographic shifts in raw material sources may affect price stability and require adaptation in extraction and synthesis.
Process intensification, continuous manufacturing, and digital process control will reduce batch variability. Expect expanded adoption of integrated quality assurance—from inline monitoring of reaction progression and impurity tracking to AI-driven batch release prediction. Downstream, flexible particle design and finishing techniques will match target application endpoints, especially for high-value grades such as injection or functional food components.
Solvent reduction, water recycling, and biomass waste minimization guide current investment in process re-engineering. Certifications around green chemistry and lifecycle impact increasingly drive customer audits. Differences in regional regulatory definitions of “green” production dictate workflow selection. Applications that demand pharmaceutical traceability push for closed-loop, minimal-waste processing, including adoption of upcycled raw caffeine from coffee and tea industrial byproducts where feasible.
Technical service engineers maintain expertise in formulation troubleshooting, process compatibility assessments, and regulatory documentation support. Guidance addresses formulation impacts of polymorph selection, particle size distribution, hygroscopicity, and interaction with excipients in finished product systems.
Field feedback often reveals challenges tied to blending kinetics, dissolution rates, and defect formation in tableting or beverage concentrates. Inhouse labs replicate client processes and develop tailored protocols for granulation, solubilization, or coating, according to the actual grade supplied. Adjustments to trace impurity profiles are made to meet specific customer validation needs, especially for regulated pharmaceutical and nutraceutical applications.
Batch-specific technical files, CoAs with expanded impurity panels, and on-request stability studies form the standard package. Ongoing batch consistency surveillance underpins complaint resolution and continuous improvement cycles. Every production lot is archived and sample-retained against customer claims, with response protocols outlined according to contractual grade requirement and jurisdictional quality provisions. Support covers guidance on optimal storage, shelf-life assessment under varied environmental conditions, and compatibility with container/closure systems used in downstream processing.
Our production of caffeine centers on meeting the specific needs of industrial customers operating within food, beverage, and pharmaceutical manufacturing. The product leaves our facility with tightly controlled particle size and verified assay through each batch. Beyond standard production, our line covers both anhydrous and monohydrate forms, giving procurement teams and R&D leads direct control over ingredient selection for finished products that rely on established ingredient behavior at scale.
Food and beverage formulators depend on consistent caffeine for functional drinks, sodas, energy shots, and flavor-modified supplements. Direct tableting and blending operations in the pharmaceutical industry require caffeine held to precise purity and moisture benchmarks. We understand the typical downstream requirements for solubility and dispersion, and monitor for byproduct or contaminant levels not only through outgoing QA checks but at key points within the upstream synthesis steps.
Full traceability follows each batch from raw material sourcing through each transformation step in our reactors and drying lines. Automated loss-in-weight dosing, filtration, and advanced drying systems deliver a reproducible profile that withstands both laboratory and production environment re-testing. Certificate of analysis data reflects readings from both in-house analytics and independent third-party verification. This approach supports regulatory documentation and supports audits from global enterprise clients.
Facilities handle packaging from 25 kg fiber drums up to palletized bulk bags. Specific lines support direct filling within cGMP conditions to suit regulated pharmaceutical processes. We support annual and quarterly supply planning for regional manufacturers and international procurement teams. Order scheduling ties to real-time inventory and forward production planning, reducing the risk of unplanned line stops or quality refusals linked to ingredient variation. Every order ships with validated seals, and each shipment number links back to manufacturing and QA data for recall control and supply chain reporting.
Our technical service team works directly with process engineers and product formulators planning new launches, scaling up existing lines, or troubleshooting plant integration. Support includes solubility consultation, compatibility checks with flavor compounds and additives, and joint process trials when new blends or delivery methods enter the market. This hands-on support helps manufacturers achieve stable product characteristics and meet shelf-life targets dictated by their own specifications.
Direct control over caffeine production distinguishes us from contract operators or brokers. Long-term supply agreements tie price, lead time, and quality commitments directly to production schedules and incoming QA footprints. Document support for global regulatory compliance—including FSSC 22000, HACCP, and ISO—reduces the time required for customer audits and new vendor onboarding. With each order, buyers gain access to detailed production records and ongoing technical updates related to regulatory changes or process enhancements.
Industrial partners in beverage, food, and pharmaceutical sectors rely on caffeine from a proven manufacturing source. Confidence in batch-to-batch consistency, responsive supply arrangements, and continuous technical engagement supports business continuity and product innovation at scale.
Caffeine, known chemically as 1,3,7-trimethylxanthine, plays a key role in food, beverage, and pharmaceutical applications. The raw material our facility processes is a white, crystalline powder graded for high solubility in hot water and moderate solubility in cold water, ethanol, and chloroform. The molecule weighs in at 194.19 g/mol. The melting point in our production batches typically ranges from 234 °C to 236 °C. Thanks to our closed-system synthesis and strict purification steps, the finished caffeine holds a consistent purity that meets the requirements demanded by leading beverage brands and pharmaceutical formulators around the world.
We monitor and control every step from neutralization through crystallization and drying, achieving regular batch purities of at least 99.5% on dry basis. High-resolution chromatography verifies each lot’s purity before release. We maintain caffeine levels well beyond the pharmacopoeial standards required for food and pharma use. Consistency minimizes downstream blending errors and reduces quality complaints, saving time and money for processors.
Caffeine’s performance in end-use applications ties directly to the absence of related alkaloids, off-odors, or solvent residues. Through our own process improvements, we control and limit unwanted xanthine derivatives and chlorinated byproducts to non-detectable levels. Low moisture content below 0.5% supports stable shelf life and granular flow properties, especially important for powered beverage operations and capsule manufacturers who rely on reliable dosing. Tight screening to eliminate particulates above 63 µm ensures smooth dispersion and uniform activity in tablets, drinks, and energy shots.
Every batch undergoes full in-house testing for purity by HPLC, moisture by Karl Fischer titration, and heavy metals using inductively coupled plasma mass spectrometry. Microbial controls and particle-size verification combine to meet both regulatory and client-specific requirements. Our documentation system provides full traceability—from incoming raw material shipments to finished product consignment—anchored by batch-specific certificates of analysis delivered with every order. Production records and retention samples support full audits and allow us to respond rapidly if a customer needs historical lot verification or additional documentation for regulatory filings.
Direct manufacturing oversight provides complete control over caffeine quality and concentration in every shipment. Customers looking for further details or performance data can rely on our technical team for prompt support, whether developing a new beverage, supplement, or pharmaceutical formulation. If a nonstandard grade is required, our process can accommodate custom particle size profiles, blending, or alternative packaging formats according to customer demand.
The strength of our reputation comes from consistently delivering material with the concentration and purity necessary for critical manufacturing sectors. Investment in analytical instrumentation, regular staff training, and strong internal quality systems ensure our caffeine supports the exacting standards of the industries we serve.
Bulk caffeine supply forms a core segment of our factory’s daily operations, touching industries from functional beverages to pharmaceuticals. Companies approach us with questions about minimum order quantity and production lead times, looking to shore up reliable supply chains and reduce downtime. Price and purity matter, but behind every order, timing and lot size shape the backbone of cost control and planning.
We set our minimum order quantity for bulk caffeine after scrutinizing a mix of technical and market realities. Our process line for synthetic and natural caffeine requires fixed set-up periods, which means running small batches undermines productivity and cost per kilogram. We cap the minimum at a ton, typically 1,000 kg, because that aligns not just with equipment efficiency but with industry-standard drum and palletized packing. Bulk handling also avoids contamination risk seen in piecemeal packaging environments and helps support competitive pricing for all customers—no matter the end application.
By committing to a minimum threshold, we also keep material flows predictable. This ensures every customer, from global beverage companies to formulators, has access to freshly produced lots that comply with food grade and pharma grade standards. Shrinking minimums introduces production interruptions, packaging waste, and increases overhead that would erode the overall value for repeat buyers.
Lead time for caffeine manufactured at scale rests on two pillars: raw material supply and batch production cycles. We manage a steady in-house inventory of raw intermediates, but large orders still involve a build-to-stock logic. Lead times for standard orders usually land in the range of four to five weeks, measured from written confirmation and cleared payment to final shipment. When customers request custom sieving, particle size adjustment, or specific documentation, add-on days may apply, but we keep communication open at every stage.
Industry events occasionally disrupt shipping lanes or port schedules, and as a direct manufacturer with in-house logistics, we plan buffer stocks to soften these shocks. Our process engineers track every lot with full traceability—something packaging lines or traders often can’t guarantee. This traceability both reduces bottlenecks and ensures every batch leaves the facility with its identity preserved for downstream certifications and local regulatory audit.
We regularly work with clients facing urgent deadlines. When demand spikes, or a critical shipment is held up by customs, our supply team can shift production slots or offer partial shipments from buffer lots. These contingency plans require strong alignment between our scheduling managers and the technical quality teams, especially for regulated segments like pharmaceuticals. Advance notice still offers the most reliable result, but our plant’s flexibility allows us to meet acute needs that traders or warehousing middlemen cannot address.
Direct lines of communication mean orders translate immediately into production targets. We update buyers on slot assignments, anticipated completion dates, and any issues in real-time. Packing configurations, from fiber drums to FIBCs, get finalized in consultation with the client’s logistics department. This minimizes risk of spillage, spoilage, or damage and guarantees the caffeine arrives in tested, factory-sealed condition.
From the floor of our manufacturing plant, minimum order quantities and lead times stand as fundamental decisions—not just hurdles—for building a robust, responsive, and cost-efficient supply chain. We stake our credibility on direct answers and solid commitments, not speculation or outsourced timelines.
Manufacturing high-purity caffeine demands strict oversight. Each batch we produce follows standardized protocols, from raw material sourcing to finished product testing. Regulations sit front and center of our daily operations, particularly as our shipments move across borders and into markets governed by different codes and standards.
Chemical shipments, especially commodities like caffeine, require more than high quality. Border authorities demand meticulous paperwork, tracking, and proof of conformity. Our team stays alert to updates in regulations from agencies such as the US FDA, European Chemicals Agency, Health Canada, and customs authorities throughout Asia, the Middle East, and South America. Shipping caffeine isn’t as simple as labelling a carton—the regulations around purity, permitted uses, and documentation differ widely. Our export documents reflect detailed batch analysis, meet the latest GHS standards, and clearly state intended use (whether pharmaceutical, food, or laboratory grade).
Regulatory changes don’t happen in isolation. For instance, the European Union’s REACH framework requires continual monitoring, documentation, and regularly updated SDSs in local languages. Some regions demand additional statements on allergens, GMOs, and pesticide residues. Lack of compliance stops containers at the port or even results in costly recalls. Years of direct shipment experience have taught us exactly where regulators focus their attention, so we anticipate changes—not chase them.
Product safety isn’t box ticking—it’s ingrained in every shift on our production floor. Each lot receives a full analytical profile, with all heavy metal and microbiological tests completed before sealing and dispatch. Finished product never leaves our factory unless it matches label claims and legal standards for caffeine content and purity. We produce and maintain full traceability records for safety audits—a legal obligation in some markets and simple good practice everywhere else.
International shipping relies on packaging built for real-world conditions, not just samples for the lab shelf. Our standard packaging uses high-barrier bags with strong exterior drums. Each drum carries clear labelling, matching internationally recognized pictograms and transport codes under the latest UN recommendations for hazardous material labelling, even if caffeine itself is not classified as a dangerous good by most freight authorities. Damaged packaging leads to border rejections and insurance woes. Our technical and logistics teams track packaging integrity all the way through to the consignee.
Regulatory authorities expect easy access to documentation. We supply up-to-date CoAs, safety data sheets, and origin certificates on request. Our technical staff support partners with clarifications on specification, documentation gaps, or local regulatory queries. If destination markets demand an additional test or legal form, we coordinate with accredited labs and supply the correct paperwork, stamped and signed.
Markets shift fast—whether driven by new national health rules, global agreements, supply chain shocks, or customer demands for cleaner ingredients. We audit regulatory developments, invest in compliance training, and upgrade documentation platforms to keep ahead of requirements. This reduces the risk of shipment delays and ensures uninterrupted supply for partners operating in competitive markets. Our production and compliance teams collaborate daily because staying legally current is integral—no shortcuts, no workarounds.
Caffeine moves across the globe under an intense regulatory spotlight. A manufacturer’s job extends far beyond raw chemical purity. Keeping every shipment legal and safe protects our brand—and, critically, the interests of everyone down the supply chain who builds on our product.
For product inquiries, sample requests, quotations or after-sales support, please feel free to contact me directly via sales3@ascent-chem.com, +8615365186327 or WhatsApp: +8615365186327
